Alternatives to NanoString Technologies

A full-stack spatial biology company.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Advancing next-generation mRNA medicines.

A vertically-integrated procurement platform for the life sciences industry.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

Developing novel therapies to reverse aging and extend lifespan.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

Scalable, one-time curative in-vivo gene editing therapies.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

AI-enabled technology for cell biology research and biopharma development.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Mapping cell-cell communication at scale in human tissue.

Developing disease-responsive advanced therapies through programmable gene control technology.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Developing breath-based diagnostics for lung diseases.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Developing an automated platform for liquid biopsy sample preparation.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Immunotherapy company targeting oncology and autoimmune diseases.

AI-powered antibody discovery platform.

Developing highly targeted, small molecule medicines.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A biotechnology company focused on oncology drug discovery.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

A global leader in clinical pharmacology and bioanalytical sciences.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Biotechnology company developing novel therapeutics by harnessing the autophagy pathway to treat serious diseases.

A biotechnology company developing genetic therapies for rare disorders.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

AI-powered knowledge discovery for life sciences.

Developing gene editing therapies to lower cholesterol.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

AI-driven biotech company engineering novel proteins for therapeutics and sustainability.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Developing novel immunotherapies and diagnostics for cancer.